Zepp Health (ZEPP)
US Market

Zepp Health (ZEPP) Income Statement


Zepp Health Income Statement

Last quarter (Q2 2022), Zepp Health's total revenue was ¥1.11B, a decrease of -39.61% from the same quarter last year. In Q2, Zepp Health's net income was ¥-106.94M. See Zepp Health’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
¥ 5.13B-¥ 6.25B¥ 6.43B¥ 5.81B¥ 3.65B
Cost of Revenue
¥ 4.14B-¥ 4.94B¥ 5.10B¥ 4.34B¥ 2.71B
Gross Profit
¥ 994.98M-¥ 1.31B¥ 1.33B¥ 1.47B¥ 939.45M
Operating Expense
¥ 1.19B-¥ 1.21B¥ 1.16B¥ 861.26M¥ 573.73M
Operating Income
¥ -193.49M-¥ 93.94M¥ 174.20M¥ 606.48M¥ 365.72M
Net Non Operating Interest Income Expense
¥ -42.56M-¥ -28.20M¥ 23.50M¥ 33.48M¥ 11.60M
Other Income Expense
¥ 71.50M-¥ 40.92M¥ 67.92M¥ 12.41M¥ 9.30M
Pretax Income
¥ -164.55M-¥ 106.67M¥ 265.61M¥ 652.37M¥ 386.61M
Tax Provision
¥ -23.03M-¥ 10.74M¥ 31.15M¥ 77.89M¥ 52.04M
Earnings From Equity Interest Net Of Tax
¥ 30.69M-¥ 41.03M¥ -4.75M¥ -1.11M¥ 1.74M
Net Income Common Stockholders
¥ -110.01M-¥ 137.80M¥ 228.75M¥ 572.75M¥ 113.49M
Basic EPS
¥ -1.84-¥ 2.20¥ 3.68¥ 9.40¥ 2.16
Diluted EPS
¥ -1.88-¥ 2.08¥ 3.52¥ 8.96¥ 2.04
Basic Average Shares
¥ 250.32M-¥ 63.04M¥ 62.12M¥ 60.91M¥ 52.97M
Diluted Average Shares
¥ 256.47M-¥ 66.09M¥ 65.09M¥ 63.99M¥ 56.26M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
¥ 1.88-¥ 3.52¥ 4.72¥ 10.32¥ 8.40
Reported Normalized Diluted E P S
¥ 1.80-¥ 3.36¥ 4.52¥ 9.80¥ 7.60
Rent Expense Supplemental
Total Expenses
¥ 5.33B-¥ 6.16B¥ 6.26B¥ 5.21B¥ 3.28B
Net Income From Continuing And Discontinued Operation
¥ -110.01M-¥ 137.80M¥ 228.75M¥ 575.20M¥ 340.05M
Normalized Income
¥ -143.50M-¥ 125.66M¥ 167.98M¥ 575.88M¥ 339.59M
Interest Expense
¥ 53.69M-¥ 44.88M¥ 22.62M--
¥ -110.86M-¥ 151.55M¥ 288.23M¥ 606.48M¥ 365.72M
¥ -110.86M-¥ 203.44M¥ 315.36M¥ 623.70M¥ 371.94M
Currency in CNY

Zepp Health Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis